Silver Book Fact

5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.

Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure. The American Journal of Medicine Web site. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715324&dopt=Abstract. Published 2004

Reference

Title
Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure
Publication
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Published 2004
Authors
Cowper, P.A., E. DeLong, D.J. Whellan, N.M. Allen LaPointe, and R.M. Califf
Volume & Issue
Volume 116, Issue 2
Pages
104-111
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Between 1981 and 2004, death rates for heart disease and stroke declined by about 44%.  
  • Disease specific status and generic health status improvements from TAVR and SAVR
    Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate risk symptomatic aortic stenosis (SAS) patients were associated with significant improvements in disease specific status (16 to…  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • From 1999-2000, average blood pressures for Americans age 40 and older would have been 10-13% higher without antihypertensive drug therapy.  
  • Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.